Skip to main content
. 2025 Feb 15;15(2):781–796. doi: 10.62347/MQQB5184

Table 1.

Comparison of baseline data between patients with pulmonary infection and the uninfected group

Factors Total Pulmonary Infection Group (n = 238) Non-infection Group (n = 406) t/Z/χ2 Value P Value
Gender 0.568 0.451
    Male 342 131 211
    Female 302 107 195
Diabetes 4.27 0.039
    Yes 132 59 73
    No 512 179 333
Hypertension 1.368 0.242
    Yes 132 43 89
    No 512 195 317
COPD 18.059 <0.001
    Yes 200 98 102
    No 444 140 304
Chemotherapy Intensity 34.299 <0.001
    Single 297 74 223
    Combination 347 164 183
Clinical Stage 1.14 0.286
    III 428 152 276
    IV 216 86 130
Chemotherapy Cycle 23.096 <0.001
    >4 232 114 118
    ≤4 412 124 288
Use of Antibiotics 5.005 0.025
    Yes 312 129 183
    No 332 109 223
Age (years) 24.17 ± 2.99 69.00 [63.00, 74.00] 64.00 [60.00, 68.00] 8.153 <0.001
BMI (kg/m2) 80.00 [70.00, 90.00] 23.97 ± 3.18 24.28 ± 2.88 -1.234 0.218
KPS Score 651.53 ± 202.61 70.00 [60.00, 80.00] 80.00 [70.00, 100.00] -8.564 <0.001
SII 39.92 [36.88, 42.97] 921.19 [807.34, 1050.80] 608.97 [500.62, 702.66] 23.125 <0.001
PNI 2.25 ± 0.90 37.50 [33.91, 41.02] 40.94 [38.27, 43.66] -9.377 <0.001
CRP (g/L) 24.17 ± 2.99 2.59 [2.13, 3.20] 1.12 [0.91, 1.37] 27.342 <0.001

Note: COPD, Chronic Obstructive Pulmonary Disease; BMI, Body Mass Index; KPS, Karnofsky Performance Status; SII, Systemic Inflammatory Index; PNI, Prognostic Nutritional Index; CRP, C-Reactive Protein.